These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 9829574)

  • 61. [Differences in cerebral glucose metabolism between frontotemporal lobar degeneration and Alzheimer's disease].
    Poljansky S; Ibach B; Vogel M; Männer P; Marienhagen J; Hajak G
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S73-5. PubMed ID: 15570509
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Midline cerebral morphometry distinguishes frontotemporal dementia and Alzheimer's disease.
    Kaufer DI; Miller BL; Itti L; Fairbanks LA; Li J; Fishman J; Kushi J; Cummings JL
    Neurology; 1997 Apr; 48(4):978-85. PubMed ID: 9109887
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Relationship between three neuropsychological tests and cerebral glucose metabolism in Alzheimer's disease].
    Zhang XQ; Min BQ; Ma YC; Yang PJ; Li DP
    Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(2):100-2. PubMed ID: 12812674
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer's disease.
    Sultzer DL; Brown CV; Mandelkern MA; Mahler ME; Mendez MF; Chen ST; Cummings JL
    Am J Psychiatry; 2003 Feb; 160(2):341-9. PubMed ID: 12562582
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment].
    Cao Q; Jiang K; Liu Y; Zhang M; Xiao S; Zuo C; Huang H
    Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(23):1613-6. PubMed ID: 12667368
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Episodic Memory Dysfunction in Behavioral Variant Frontotemporal Dementia: A Clinical And FDG-PET Study.
    Fernández-Matarrubia M; Matías-Guiu JA; Cabrera-Martín MN; Moreno-Ramos T; Valles-Salgado M; Carreras JL; Matías-Guiu J
    J Alzheimers Dis; 2017; 57(4):1251-1264. PubMed ID: 28304289
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In vivo amyloid imaging with PET in frontotemporal dementia.
    Engler H; Santillo AF; Wang SX; Lindau M; Savitcheva I; Nordberg A; Lannfelt L; Långström B; Kilander L
    Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):100-6. PubMed ID: 17846768
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differences of apathy perfusion correlates between Alzheimer's disease and frontotemporal dementia. A 99mTc-HMPAO SPECT study with automated Brodmann areas analysis.
    Valotassiou V; Sifakis N; Tzavara C; Lykou E; Tsinia N; Kamtsadeli V; Sali D; Angelidis G; Psimadas D; Tsougos I; Papageorgiou SG; Georgoulias P; Papatriantafyllou J
    Int J Psychiatry Clin Pract; 2022 Mar; 26(1):14-22. PubMed ID: 33207961
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT.
    Tripathi M; Tripathi M; Damle N; Kushwaha S; Jaimini A; D'Souza MM; Sharma R; Saw S; Mondal A
    Neuroradiol J; 2014 Feb; 27(1):13-21. PubMed ID: 24571830
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cortical abnormalities in Alzheimer's disease.
    Foster NL; Chase TN; Mansi L; Brooks R; Fedio P; Patronas NJ; Di Chiro G
    Ann Neurol; 1984 Dec; 16(6):649-54. PubMed ID: 6335378
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia.
    Peters F; Perani D; Herholz K; Holthoff V; Beuthien-Baumann B; Sorbi S; Pupi A; Degueldre C; Lemaire C; Collette F; Salmon E
    Dement Geriatr Cogn Disord; 2006; 21(5-6):373-9. PubMed ID: 16534207
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer's disease.
    McNeill R; Sare GM; Manoharan M; Testa HJ; Mann DM; Neary D; Snowden JS; Varma AR
    J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):350-5. PubMed ID: 17158559
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators.
    Alavi A; Newberg AB; Souder E; Berlin JA
    J Nucl Med; 1993 Oct; 34(10):1681-7. PubMed ID: 8410281
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Characteristics of cerebral glucose utilization in dementia.
    Matsuzawa T; Matsui H; Meguro K; Ueda M; Yamada K; Yamaguchi T; Itoh M; Hatazawa J; Kinomura S
    Sci Rep Res Inst Tohoku Univ Med; 1990 Dec; 37(1-4):11-21. PubMed ID: 2103655
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Assessment of mental deterioration with the Cognitive Abilities Screening Instrument (CASI) and glucose hypometabolism in Alzheimer's disease: the Osaki-Tajiri Project.
    Yamaguchi S; Meguro K; Ishii H; Meguro M; Akanuma K
    J Clin Neurosci; 2009 Nov; 16(11):1430-4. PubMed ID: 19632119
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Differential diagnosis of Alzheimer's disease with PET.
    Salmon E; Sadzot B; Maquet P; Degueldre C; Lemaire C; Rigo P; Comar D; Franck G
    J Nucl Med; 1994 Mar; 35(3):391-8. PubMed ID: 8113882
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Age- and sex-associated changes in cerebral glucose metabolism in normal healthy subjects: statistical parametric mapping analysis of F-18 fluorodeoxyglucose brain positron emission tomography.
    Kim IJ; Kim SJ; Kim YK
    Acta Radiol; 2009 Dec; 50(10):1169-74. PubMed ID: 19922315
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: two sides of the same coin?
    Verfaillie SC; Adriaanse SM; Binnewijzend MA; Benedictus MR; Ossenkoppele R; Wattjes MP; Pijnenburg YA; van der Flier WM; Lammertsma AA; Kuijer JP; Boellaard R; Scheltens P; van Berckel BN; Barkhof F
    Eur Radiol; 2015 Oct; 25(10):3050-9. PubMed ID: 25899416
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Brain reserve capacity in frontotemporal dementia: a voxel-based 18F-FDG PET study.
    Perneczky R; Diehl-Schmid J; Drzezga A; Kurz A
    Eur J Nucl Med Mol Imaging; 2007 Jul; 34(7):1082-7. PubMed ID: 17219132
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Relative glucose metabolic rate higher in white matter in patients with schizophrenia.
    Buchsbaum MS; Buchsbaum BR; Hazlett EA; Haznedar MM; Newmark R; Tang CY; Hof PR
    Am J Psychiatry; 2007 Jul; 164(7):1072-81. PubMed ID: 17606659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.